We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BURLINGTON, Mass., Oct. 13, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), announced that it has acquired the biologic patch business of Admedus Ltd (ASX: AHZ) for $15.5...
/newsletter/barneyc/517/admedus-ltd-gets-fda-approval-for-launch-of-vascucel-in-us
http://www.fool.com.au/2015/03/12/heres-why-admedus-ltd-shares-have-gone-gangbusters-2/
CardioCel® now able to be marketed in the US Adds to EU approval in 2013 Platform for growth in revenue for Admedus Admedus (ASX:AHZ) today announced it has received FDA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 7.13 | 7922.22222222 | 0.09 | 9.18 | 0.055 | 309592 | 0.13712855 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions